戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y to experience adverse side-effects such as postoperative nausea.
2 r the prevention of chemotherapy-induced and postoperative nausea and vomiting (CINV and PONV).
3  delivery, but is frequently associated with postoperative nausea and vomiting (PONV) and pruritus.
4                                              Postoperative nausea and vomiting (PONV) continues to be
5 amethasone given before thyroidectomy reduce postoperative nausea and vomiting (PONV) in a randomized
6 : The purpose of this review is to highlight postoperative nausea and vomiting (PONV), to discuss why
7 ith known comorbidities including migraines, postoperative nausea and vomiting (PONV), vertigo and mo
8 f 5mg/day, the current dose for treatment of postoperative nausea and vomiting (PONV).
9 g conditions, various measures of awakening, postoperative nausea and vomiting and discharge from the
10 rd for treatment of chemotherapy-induced and postoperative nausea and vomiting and have potential for
11 armamentarium available to treat and prevent postoperative nausea and vomiting continues to expand.
12 ost successful approach to the prevention of postoperative nausea and vomiting is multimodal, with co
13  The cost-effectiveness of such screening in postoperative nausea and vomiting management has, howeve
14 rioperative administration of droperidol for postoperative nausea and vomiting on the basis of the po
15 ng patients include female sex, a history of postoperative nausea and vomiting or motion sickness, yo
16     Common variables that identify high-risk postoperative nausea and vomiting patients include femal
17 nse with reference to emergence delirium and postoperative nausea and vomiting prevention to outline
18 drugs, both new and old, and their impact on postoperative nausea and vomiting prophylaxis and treatm
19  Routine regional anesthesia use, multimodal postoperative nausea and vomiting prophylaxis, multimoda
20 We also discuss 'multimodalities' addressing postoperative nausea and vomiting prophylaxis, periopera
21 based anesthesia satisfaction data, limiting postoperative nausea and vomiting remains a major patien
22 mal strategy for prevention and treatment of postoperative nausea and vomiting remains uncertain.
23 miting, new clinical studies provide revised postoperative nausea and vomiting risk prediction tools,
24           Given the multifactorial nature of postoperative nausea and vomiting, a multimodal approach
25 pression, atelectasis, pneumonia, ileus, and postoperative nausea and vomiting, and also improved rec
26 procedures of the breast and axilla, reduces postoperative nausea and vomiting, and provides prolonge
27 dle ear surgery leads to a high incidence of postoperative nausea and vomiting, and these are best ma
28 r antagonists has improved the management of postoperative nausea and vomiting, but has not completel
29 preventing or rapidly rescuing patients from postoperative nausea and vomiting, new clinical studies
30          There remains a finite incidence of postoperative nausea and vomiting, particularly among hi
31              This review complements data on postoperative nausea and vomiting, suggesting a biologic
32  that this drug does reduce the incidence of postoperative nausea and vomiting, with somewhat delayed
33 ensive alternative medications used to treat postoperative nausea and vomiting.
34 from clinical practice for the indication of postoperative nausea and vomiting.
35 nd their potential role in the management of postoperative nausea and vomiting.
36 re included for management and prevention of postoperative nausea and vomiting.
37 onists and the impact of pharmacogenetics on postoperative nausea and vomiting.
38  children undergoing tonsillectomy to reduce postoperative nausea and vomiting; however, they might i
39 postoperative complications, operative time, postoperative nausea, length of hospital stay, recurrenc
40 creening Tool (MST) score, 3-d food records, postoperative nausea, LOS, and complications.
41     Dexamethasone is effective in preventing postoperative nausea without increased risk of bleeding.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。